查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830516

吻合器市場按應用、最終用途、技術、程序類型、分銷管道和材料類型分類－2025-2032 年全球預測

Anastomosis Devices Market by Application, End Use, Technology, Procedure Type, Distribution Channel, Material Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年吻合器市場規模將成長至 57.1 億美元，複合年成長率為 8.19%。

主要市場統計數據
基準年2024年 30.4億美元
預計2025年 32.9億美元
預測年份：2032年 57.1億美元
複合年成長率（%） 8.19%

全面介紹當代吻合器領域，重點在於臨床促進因素、創新載體和醫療保健系統中的採購重點

隨著臨床對改善手術效果的需求與器械層面的快速創新相融合，吻合器領域正處於曲折點。本報告首先探討了外科醫生、醫院管理人員和器械製造商如何應對日益複雜的臨床、監管和商業考慮。隨著器械人體工學、組織相容性材料和手術專用工具的不斷改進，相關人員正在重新調整其採購和產品藍圖，以反映不斷變化的臨床偏好和手術工作流程。

隨著微創手術成為心血管和消化器官系統領域廣泛治療的標準，器械開發商正致力於開發注重可重複性、縮短手術時間和增強組織癒合能力的系統。同時，支付方和醫療系統也更加重視基於價值的治療結果。因此，製造商不僅要展示其技術性能，還要展示其與護理路徑、培訓計劃和庫存管理的整合。本引言概述了報告探討的核心主題，並向讀者介紹了在不久的將來影響臨床應用和商業競爭的關鍵促進因素。

深入分析影響吻合器市場競爭優勢和採用動態的技術、臨床和監管變化

吻合器市場正在經歷一場變革性的轉變，其驅動力來自於技術、臨床實踐和供應鏈韌性的融合。同時，可生物分解材料和複合材料的進步正在促進組織整合，並減少長期異物反應。這些技術變革並非孤立發生；它們影響培訓專案、通訊協定和設備服務模式，因此需要採取整體的商業化方法。

臨床上，外科醫師越來越青睞能夠最大程度減少組織創傷、加速復原的手術，這推動了微創手術的廣泛應用。隨著醫院和門診手術中心不斷改進手術全期路徑，以最佳化手術量和病患體驗，器械供應商必須使其產品開發與不斷發展的治療趨勢保持一致。同時，監管審查的加強和對上市後監管的加強，使得品質保證和證據生成成為商業性的必要條件。總而言之，這些趨勢正在重塑競爭優勢，差異化越來越依賴臨床證據、綜合服務和靈活應變的分銷模式的結合。

深入探討 2025 年前美國新關稅政策將如何影響醫療設備供應鏈的製造足跡、分銷策略和採購動態。

美國將於2025年開始實施新關稅，這為醫療設備製造商和醫療保健系統買家的供應鏈和定價策略帶來了複雜性。關稅調整正在影響各通路的採購決策，迫使他們重新評估製造佈局，並影響供應商和醫療保健系統買家之間的談判。為此，許多製造商正在考慮近岸外包、區域組裝中心和多元化採購，以緩解成本壓力，同時保持品管和前置作業時間的可靠性。

除了直接成本影響外，關稅還可能影響通路動態，因為它會改變直銷與第三方分銷的相對競爭力，並鼓勵數位和線上銷售管道降低中階成本。醫療保健提供者現在會更謹慎地評估總體擁有成本，將物流風險、與材料選擇相關的預期設備壽命以及潛在的合規成本納入考慮。簡言之，關稅主導的變化強化了供應鏈敏捷性和合約彈性作為吻合器領域商業策略核心要素的重要性。

基於細分的詳細洞察揭示了影響需求的臨床適應症、最終使用環境、技術類型、程序方法、分銷管道和材料選擇

該細分提供了一個分析框架，用於理解創新和需求在臨床和商業軸線上的交匯點。該結構揭示了臨床適應症如何驅動器械設計的優先事項，例如管腔尺寸相容性、強化策略和止血控制。根據最終用途，市場在門診手術中心、醫院和專科診所進行研究，揭示了基於病例組合、資本預算和消毒資源的採購行為差異。

技術細分透過手動和電動解決方案來考察市場，從而可以對易用性、訓練負擔和對手術時間的影響進行差異化評估。根據手術類型，市場透過微創和開放性手術方法來考察，隨著微創技術在許多適應症中繼續取代傳統開放性手術，重點在於採用軌跡。根據銷售管道，市場考察直銷、線上銷售和第三方經銷商，重點關注通路經濟性、服務期望和售後支援需求。最後，根據材料類型，市場檢視可生物分解、複合材料和鈦合金選項，以了解組織相容性、機械完整性和長期植入行為之間的權衡。這些細分揭示了臨床需求、報銷動態和營運現實的交匯點，從而創造了機會和競爭壓力。

從戰略區域觀點美洲、歐洲、中東和非洲以及亞太地區的不同醫療保健系統如何需要不同的商業化策略和監管策略

區域動態對於產品開發、監管策略和商業擴張的策略規劃至關重要。美洲的醫療保健系統由先進的三級醫療中心和社區醫院組成，其綜合護理網路、報銷模式和捆綁支付結果驅動購買決策。這種環境有利於擁有可靠臨床證據和可擴展訓練計畫的系統。在歐洲、中東和非洲，監管多樣性和醫院採購結構促使製造商尋求量身定做的打入市場策略，在重點核准和本地夥伴關係關係之間取得平衡。同時，某些市場的成本敏感度鼓勵模組化產品供應和靈活的商業模式。

受外科手術能力提升、微創治療項目擴展以及政府主導的醫療保健投資的推動，亞太市場呈現出多樣化的成長和應用模式。服務這些市場的供應商通常透過將本地化製造和組裝與協作培訓和臨床教育計劃相結合來加速應用。不同地區的供應鏈彈性、關稅影響和分銷生態系統存在差異，這要求企業採用針對特定地區的策略，將監管前瞻性、戰略夥伴關係和靈活的定價結構整合在一起，才能在碎片化的全球格局中取得成功。

權威的競爭動態概述，展示平台策略、臨床證據產生和策略夥伴關係關係將如何決定吻合術解決方案的市場領導地位

吻合器領域的競爭態勢由成熟的醫療設備公司和敏捷的專業創新者所構成。主要企業專注於開發整合器械、耗材和操作培訓的平台，以與外科團隊和醫院系統建立穩固的合作關係。這些公司通常透過多中心研究和上市後註冊來投資以取得臨床證據，以證明產品的比較性能並支持報銷談判。同時，規模較小、專注於技術的參與企業則致力於利用獨特的材料科學或自動化技術，探索利基應用，以解決特定的臨床痛點。

夥伴關係和策略聯盟正日益普遍，這使得大型機構能夠利用有針對性的技術擴充產品系列，同時實現規模化和分銷。同時，原始設備製造商 (OEM) 和合約製造商正在從單純的生產合作夥伴發展成為共同開發的合作夥伴，提供設備工程、法規遵循和成本最佳化方面的專業知識。整體競爭格局有利於那些能夠將臨床可靠性與製造、供應鏈和客戶支援方面的卓越營運相結合的公司。

為設備製造商提供可行的策略建議，以協調創新、臨床證據和彈性商業模式，確保其在醫療保健環境中的持久採用

產業領導者應優先考慮採用整合方法，將產品創新與臨床工作流程、供應鏈韌性和證據產生結合。投資強大的設備平台和直覺的使用者介面，有助於在醫院和門診環境中實現產品差異化，同時降低手術結果的差異性。同時，多樣化材料組合，包括可生物分解材料和複合材料，可以解決臨床醫生偏好的差異性和長期安全問題。重要的是，製造商必須建立臨床項目，以產生可靠的真實世界數據和外科醫生主導的證據，從而支持產品採用和支付方對話。

從營運角度來看，企業應審查籌資策略，以降低關稅風險和物流風險，包括區域組裝和策略性供應商多元化等選項。商業性，根據醫院、門診手術中心和專科診所的需求客製化分銷策略可以提高市場滲透率。這可以包括將專科醫生直銷與高周轉率耗材的線上訂購選項相結合的混合模式。最後，投資於全面的培訓、測試和基於價值的合約可以加強與醫療保健提供者的關係，並將醫療設備嵌入其護理路徑中，從而在競爭格局中創造持久優勢。

一種透明的調查方法，結合定性專家訪談、監管和臨床文獻綜述以及情境分析檢驗策略結論和建議

本研究將對外科專家、採購主管和設備工程師的定性訪談與對監管文件、臨床文獻和公開的機構採購慣例的二次分析相結合。調查方法和資料來源強調跨資料來源的三角測量，以確保研究結果既能反映臨床實際情況，又能兼顧商業性約束。關鍵輸入包括：結構化訪談（旨在揭示從業者偏好）、採購和培訓項目的案例研究分析，以及對設備設計和材料的技術評審（旨在評估性能權衡）。

分析技術包括比較情境分析（用於評估資費變化和分銷策略的影響），以及細分映射（用於識別優先應用和最終用途叢集）。品質保證流程包括來源檢驗和專家評審小組，以支援解讀並完善建議的行動。這種方法無需依賴專有市場規模，即可為產品開發、上市規劃和組織設計提供實際的洞察。

結論總結強調，實證創新、供應鏈彈性和綜合商業化對於實現持續的臨床和商業性成功至關重要

總而言之，吻合器市場的特點是臨床創新、材料科學進步和不斷變化的商業性壓力之間的動態相互作用。要在這個市場取得成功，需要同時專注於提供可重複的手術結果，並建立一個能夠適應當地監管和經濟波動的、有彈性的、循證的商業模式。將強大的器材、多樣化的材料選擇和強大的臨床培訓項目整合成一個連貫的價值提案的利益相關人員，將最有能力滿足臨床醫生的需求和機構的採購標準。

展望未來，企業應維持供應鏈規劃的敏捷性，並優先考慮能夠加速臨床認可的夥伴關係。透過使產品藍圖與微創治療的程序趨勢保持一致，並投資於買家所需的真實世界證據，製造商和投資者可以創造永續的競爭差異化，並幫助改善不同醫療環境中的患者治療效果。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 機器人吻合裝置在結直腸手術中的廣泛應用，採用增強型關節和精密機器人
  • 生物可吸收聚合物技術在血管和胃腸道吻合術中的整合，以減少長期併發症
  • 開發具有即時洩漏偵測和術後監測功能的物聯網吻合系統
  • 推廣使用一次性吻合器，以最大限度地減少交叉污染並簡化醫院的手術工作流程
  • 實施 3D 列印的患者專用吻合環，以改善複雜切除術中的貼合度和密封性。
  • 監管部門的核准推動了雷射和先進能量吻合口封閉設備在關鍵市場的商業化
  • 利用高頻超音波引導開發微創腹腔鏡吻合平台，可實現精確的組織近似
  • 增加對外科醫生培訓模擬器和虛擬實境模組的投資，以掌握先進的吻合裝置技術
  • 隨著醫療保健基礎設施的不斷擴大，亞太地區對具有成本效益的一次性醫療設備的需求日益成長。
  • 重點介紹健康經濟學研究，證明新的吻合技術可以提高成本效益並減少住院時間

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章吻合器市場（按應用）

  • 心血管系統
    • 冠狀動脈
    • 血管
  • 消化器官系統
    • 冒號
    • 食道
    • 胃

9. 吻合器材市場（依最終用途）

  • 門診手術中心
  • 醫院
  • 專科診所

第 10 章 吻合器市場（依技術）

  • 手動的
  • 供電

第 11 章吻合器市場（依手術類型）

  • 微創
  • 開放性手術

第 12 章吻合器市場（依通路）

  • 直銷
  • 網上銷售
  • 第三方經銷商

第13章 吻合器市場（依材料類型）

  • 可生物分解
  • 合成的
  • 鈦

第14章吻合器市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章吻合器市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 吻合器市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Johnson & Johnson
    • Medtronic plc
    • B. Braun Melsungen AG
    • Stryker Corporation
    • Getinge AB
    • Terumo Corporation
    • ConMed Corporation
    • Cardinal Health, Inc.
    • Teleflex Incorporated
    • Baxter International Inc.
Product Code: MRR-431F213C91D8

The Anastomosis Devices Market is projected to grow by USD 5.71 billion at a CAGR of 8.19% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.04 billion
Estimated Year [2025] USD 3.29 billion
Forecast Year [2032] USD 5.71 billion
CAGR (%) 8.19%

Comprehensive introduction to the contemporary anastomosis devices landscape highlighting clinical drivers, innovation vectors, and procurement priorities for healthcare systems

The anastomosis devices sector stands at an inflection point as clinical demand for improved surgical outcomes converges with rapid device-level innovation. This report opens by framing the contemporary landscape in which surgeons, hospital administrators, and device manufacturers navigate an increasingly complex set of clinical, regulatory, and commercial considerations. Building on sustained improvements in instrument ergonomics, tissue-compatible materials, and procedure-specific tooling, stakeholders are recalibrating procurement and product road maps to reflect evolving clinical preferences and procedural workflows.

As minimally invasive techniques become standard of care across a widening range of cardiovascular and gastrointestinal procedures, device developers are responding with systems that emphasize reproducibility, reduced operative time, and enhanced tissue healing. Concurrently, payers and health systems are placing greater emphasis on value-based outcomes. Consequently, manufacturers must demonstrate not only technical performance but also integration with care pathways, training programs, and inventory management. This introduction establishes the core themes examined throughout the report and orients readers to the major drivers shaping near-term clinical adoption and commercial competition.

Detailed analysis of the technological, clinical, and regulatory shifts reshaping competitive advantage and adoption dynamics in the anastomosis devices market

The anastomosis devices landscape is undergoing transformative shifts driven by convergent forces in technology, clinical practice, and supply chain resilience. On the technology front, powered instrumentation and intelligent device interfaces are improving precision and consistency across complex anastomoses, while advances in biodegradable and composite materials are enhancing tissue integration and reducing long-term foreign body reactions. These technological shifts are not isolated; they influence training programs, procedural protocols, and device servicing models, necessitating a holistic approach to commercialization.

Clinically, surgeons are increasingly favoring techniques that minimize tissue trauma and shorten recovery, which has catalyzed broader adoption of minimally invasive approaches. As hospitals and ambulatory surgical centers refine perioperative pathways to optimize throughput and patient experience, device suppliers must align product development with the evolving cadence of care. Meanwhile, regulatory scrutiny and greater emphasis on post-market surveillance are elevating quality assurance and evidence-generation as commercial imperatives. Taken together, these trends are reshaping competitive advantage, where differentiation increasingly depends on a combination of clinical evidence, integrated services, and adaptable distribution models.

Insightful examination of how new United States tariff policies for 2025 are influencing manufacturing footprints, distribution strategies, and procurement dynamics in device supply chains

The introduction of new tariff measures in the United States for 2025 has introduced an added layer of complexity to supply chain and pricing strategies for device manufacturers and health system purchasers. Tariff adjustments influence procurement decisions across distribution channels, compel reassessment of manufacturing footprints, and shape negotiations between suppliers and institutional buyers. In response, many manufacturers are examining near-shoring, regional assembly hubs, and diversified sourcing to mitigate cost pressure while maintaining quality controls and lead-time reliability.

Beyond direct cost implications, tariffs can affect channel dynamics by altering the relative competitiveness of direct sales versus third-party distribution, and by incentivizing digital and online sales channels that reduce middle-tier costs. Healthcare providers are evaluating total cost of ownership with greater scrutiny, factoring in logistics risk, expected device longevity tied to material selection, and potential regulatory compliance costs. In short, tariff-driven shifts are reinforcing the importance of supply chain agility and contractual flexibility as central components of commercial strategy in the anastomosis devices sector.

In-depth segmentation-driven insights revealing clinical indications, end-use environments, technology types, procedure approaches, distribution channels, and material choices shaping demand

Segmentation provides the analytical framework to understand where innovation and demand converge across clinical and commercial axes. Based on application, the market is studied across cardiovascular and gastrointestinal procedures, with cardiovascular further divided into coronary and vascular, and gastrointestinal split into colorectal, esophageal, and gastric; this structure highlights how clinical indications drive device design priorities such as lumen size compatibility, reinforcement strategies, and hemostasis control. Based on end use, the market is studied across ambulatory surgical center, hospitals, and specialty clinic settings, revealing divergent procurement behaviors driven by case mix, capital budgets, and sterilization resources.

Drawing on technology segmentation, the market is studied across manual and powered solutions, enabling differential assessments of usability, training burden, and procedure time impacts. Based on procedure type, the market is studied across minimally invasive and open surgery approaches, which clarifies adoption trajectories as minimally invasive techniques continue to displace traditional open procedures for many indications. Based on distribution channel, the market is studied across direct sales, online sales, and third party distributors, which surfaces channel economics, service expectations, and aftermarket support requirements. Lastly, based on material type, the market is studied across biodegradable, composite, and titanium options to capture trade-offs between tissue compatibility, mechanical integrity, and long-term implant behavior. Together, these segmentations illuminate where clinical needs, reimbursement dynamics, and operational realities intersect to create pockets of opportunity and competitive pressure.

Strategic regional perspective on how diverse healthcare systems across the Americas, Europe Middle East & Africa, and Asia-Pacific require tailored commercialization tactics and regulatory strategies

Regional dynamics are central to strategic planning for product development, regulatory strategy, and commercial deployment. In the Americas, healthcare systems display a mix of advanced tertiary centers and community hospitals where purchasing decisions are influenced by integrated care networks, reimbursement models, and emphasis on bundled payment outcomes; this environment favors systems with robust clinical evidence and scalable training programs. In Europe, Middle East & Africa, regulatory heterogeneity and varying hospital procurement structures lead manufacturers to pursue tailored market entry strategies that balance centralized approvals with local partnerships, while cost-sensitivity in certain markets encourages modular product offerings and flexible commercial models.

Asia-Pacific markets present a diverse set of growth and adoption patterns driven by rising surgical capacity, expansion of minimally invasive programs, and government-led healthcare investments. Suppliers engaging these markets often combine localized manufacturing or assembly with collaborative training and clinical education initiatives to accelerate adoption. Across all regions, differences in supply chain resilience, tariff exposure, and distribution ecosystems require companies to adopt region-specific playbooks that integrate regulatory foresight, strategic partnerships, and adaptable pricing structures to succeed in a fragmented global landscape.

Authoritative overview of competitive dynamics showing how platform strategies, clinical evidence generation, and strategic partnerships determine market leadership in anastomosis solutions

Competitive dynamics in the anastomosis devices space are shaped by a mix of established medical device firms and agile specialized innovators. Leading companies are focusing on platform development that integrates instrumentation, consumables, and procedural training to create sticky relationships with surgical teams and hospital systems. These firms are investing in clinical evidence generation, often through multi-center studies and post-market registries, to demonstrate comparative performance and to support reimbursement discussions. At the same time, smaller, technology-focused entrants are pursuing niche applications with unique material science or automation features that address specific clinical pain points.

Partnerships and strategic alliances are increasingly common, enabling larger organizations to augment product portfolios with targeted technologies while providing scale and distribution reach. Concurrently, OEM and contract manufacturers are evolving from pure production partners into co-development collaborators, offering expertise in device engineering, regulatory navigation, and cost optimization. The overall competitive environment rewards companies that can combine clinical credibility with operational excellence in manufacturing, supply chain, and customer support.

Actionable strategic recommendations for device makers to align innovation, clinical evidence, and resilient commercial models to secure durable adoption across care settings

Industry leaders should prioritize an integrated approach that aligns product innovation with clinical workflows, supply chain resilience, and evidence generation. Investing in powered device platforms and intuitive user interfaces can reduce variance in surgical outcomes while differentiating offerings in hospital and ambulatory settings. In parallel, diversifying material portfolios to include biodegradable and composite options will address clinician preference variability and long-term safety considerations. Importantly, manufacturers should structure clinical programs that generate robust real-world data and surgeon-led evidence to support adoption and payer dialogue.

From an operational perspective, firms must reassess sourcing strategies to mitigate tariff exposure and logistics risk, including options for regional assembly and strategic vendor diversification. Commercially, tailoring distribution strategies to the needs of hospitals, ambulatory surgical centers, and specialty clinics will improve market penetration; this can include hybrid models combining direct specialist sales with online ordering options for high-turn consumables. Finally, investing in comprehensive training, proctoring, and value-based contracting will strengthen provider relationships and embed devices within care pathways, creating durable advantages in a competitive landscape.

Transparent research methodology combining qualitative expert interviews, regulatory and clinical literature review, and scenario analysis to validate strategic conclusions and recommendations

This study synthesizes primary qualitative interviews with surgical specialists, procurement leaders, and device engineers alongside secondary analysis of regulatory filings, clinical literature, and publicly available institutional procurement practices. The methodology emphasizes triangulation across data sources to ensure findings reflect both clinical realities and commercial constraints. Key inputs include structured interviews to surface practitioner preferences, case study analysis of procurement and training programs, and technical reviews of device designs and materials to assess performance trade-offs.

Analytical techniques incorporate comparative scenario analysis to evaluate impacts of tariff changes and distribution strategies, as well as segmentation mapping to identify high-priority application and end-use clusters. Quality assurance processes included source validation and expert review panels to corroborate interpretations and to refine recommended actions. This approach produces insights that are actionable for product development, go-to-market planning, and organizational design without relying on proprietary market sizing.

Concluding synthesis emphasizing the imperative for evidence-backed innovation, supply chain resilience, and integrated commercialization to achieve sustained clinical and commercial success

In conclusion, the anastomosis devices sector is characterized by dynamic interplay between clinical innovation, material science advances, and shifting commercial pressures. Success in this market requires a dual focus on delivering reproducible surgical performance and on building resilient, evidence-backed commercial models that can adapt to regional regulatory and economic variability. Stakeholders that integrate powered instrumentation, versatile material options, and strong clinical training programs into a coherent value proposition will be best positioned to meet clinician needs and institutional purchasing criteria.

Moving forward, companies should maintain agility in supply chain planning and prioritize partnerships that accelerate clinical acceptance. By aligning product road maps with the procedural trends toward minimally invasive care and by investing in the real-world evidence that buyers demand, manufacturers and investors can create sustainable competitive differentiation and support improved patient outcomes across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Widespread adoption of robotic assisted anastomosis devices for colorectal procedures using enhanced articulation and precision robotics
  • 5.2. Integration of bioabsorbable polymer technologies in vascular and gastrointestinal anastomosis for reduced long term complications
  • 5.3. Development of IoT enabled anastomosis systems with real time leak detection and postoperative monitoring capabilities
  • 5.4. Expansion of single use anastomosis staplers to minimize cross contamination and streamline surgical workflow in hospitals
  • 5.5. Implementation of 3D printed patient specific anastomotic rings to improve fit and sealing performance in complex resections
  • 5.6. Regulatory approvals driving the commercialization of laser based and advanced energy anastomosis sealing devices across major markets
  • 5.7. Growth of minimally invasive laparoscopic anastomosis platforms with high frequency ultrasound guidance for precise tissue approximation
  • 5.8. Increased investment in surgeon training simulators and virtual reality modules for mastering advanced anastomosis device techniques
  • 5.9. Rising demand in Asia Pacific for cost effective disposable anastomosis devices supported by expanding healthcare infrastructure
  • 5.10. Focus on health economic studies demonstrating improved cost effectiveness and reduced length of stay with novel anastomosis technology

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anastomosis Devices Market, by Application

  • 8.1. Cardiovascular
    • 8.1.1. Coronary
    • 8.1.2. Vascular
  • 8.2. Gastrointestinal
    • 8.2.1. Colorectal
    • 8.2.2. Esophageal
    • 8.2.3. Gastric

9. Anastomosis Devices Market, by End Use

  • 9.1. Ambulatory Surgical Center
  • 9.2. Hospitals
  • 9.3. Specialty Clinic

10. Anastomosis Devices Market, by Technology

  • 10.1. Manual
  • 10.2. Powered

11. Anastomosis Devices Market, by Procedure Type

  • 11.1. Minimally Invasive
  • 11.2. Open Surgery

12. Anastomosis Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Online Sales
  • 12.3. Third Party Distributors

13. Anastomosis Devices Market, by Material Type

  • 13.1. Biodegradable
  • 13.2. Composite
  • 13.3. Titanium

14. Anastomosis Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Anastomosis Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Anastomosis Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Johnson & Johnson
    • 17.3.2. Medtronic plc
    • 17.3.3. B. Braun Melsungen AG
    • 17.3.4. Stryker Corporation
    • 17.3.5. Getinge AB
    • 17.3.6. Terumo Corporation
    • 17.3.7. ConMed Corporation
    • 17.3.8. Cardinal Health, Inc.
    • 17.3.9. Teleflex Incorporated
    • 17.3.10. Baxter International Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. ANASTOMOSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. ANASTOMOSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANASTOMOSIS DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 312. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 313. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 314. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 315. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 316. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 317. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 318. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 319. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 322. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 323. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPEAN UNION ANA